Press release
Antihormonal Cancer Therapies Market Strategic Analysis to Understand the Competitive Outlook of the Industry, 2030
Hormones are chemicals that are naturally produced by the organs and regulate just about every cell in the body. Hormone therapy is also known as endocrine therapy. Insulin, thyroid hormone, epinephrine, cortisol, testosterone, and estrogen are some examples of hormones.
Read Report Overview - https://www.transparencymarketresearch.com/antihormonal-cancer-therapies-market.html
Key Drivers and Opportunities of Global Antihormonal Cancer Therapies Market
Increase in incidence and prevalence of cancer such as breast cancer and prostate cancer is anticipated to drive the antihormonal cancer therapies market. For instance, according to a study conducted by Breastcancer.org, in 2020, estimated 12% women in U.S. are likely to develop invasive breast cancer over the lifetime and estimated 48,530 new cases of non-invasive (in situ) breast cancer along with 276,480 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S.
According to the American Cancer Society, Inc., in 2017, estimated 63,410 in situ cases, 252,710 invasive cases and 40,610 deaths in all ages due to breast cancer were recorded in U.S.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76970
Moreover, rise in demand for newer agents that aim to circumvent resistance and combination therapies is leading to fuel the growth of antihormonal therapies. Thus, the industry players are engaged in research and development in order to develop new products and therapies. For instance, U.S. Food and drug Administration approved Piqray in May 2019 to be used in combination with the FDA-approved endocrine therapy fulvestrant, to treat postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced, or metastatic breast cancer.
Furthermore, increase in government and private organization initiatives to increase awareness regarding the cancer treatment is likely to propel the market. For instance, the World Health Organization promotes breast cancer control within the context of comprehensive national cancer control programs.
Request for Analysis of Covid-19 Impact on Antihormonal Cancer Therapies Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=76970
The incidence rate of breast and prostate cancer has been increasing steadily in developing countries. Prostate cancer is one of the leading cancers in India. For instance, according to Cytecare Hospital, estimated 26,120 and 28,079 cases of prostate cancer were reported in 2010 and 2015, respectively, in India. Moreover, the five-year survival rate for prostate cancer in India was 64%.
Moreover, governments in developing countries are making significant investments toward modernization of health care infrastructure which is likely to increase access to health care
Thus, rising prevalence and government initiatives in developing countries present lucrative opportunities in the global market
North America to Capture Major Share of Global Antihormonal Cancer Therapies Market
North America is expected to account for major share of the global antihormonal cancer therapies market due to high prevalence of cancer. Moreover, early adoption of advanced therapies is anticipated to drive the market in the region.
The antihormonal cancer therapies market in Asia Pacific is expected to grow at a rapid pace during the forecast period, owing to rise in awareness and increase in cases of cancer
Pre Book Antihormonal Cancer Therapies Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=76970<ype=S
Key Players Operating in Global Antihormonal Cancer Therapies Market
The global antihormonal cancer therapies market is highly concentrated due to the presence of key players. A large number of manufacturers hold major share in their respective regions. Demand for antihormonal cancer therapies products has increased in emerging as well as developed markets. Growth strategies adopted by leading players and focus on research and development are the key factors likely to drive the global antihormonal cancer therapies market.
Major players operating in the global antihormonal cancer therapies market are:
Bristol-Myers Squibb Pharmaceuticals
AstraZeneca
Novartis AG
Pfizer Inc.
AbbVie Inc.
More Trending Reports by Transparency Market Research –
Home Blood Pressure Monitoring Devices Market: https://www.biospace.com/article/home-blood-pressure-monitoring-devices-market-increasing-in-awareness-regarding-advantages-of-home-bp-machines-and-launch-of-new-advanced-home-bp-monitors-to-drive-market/
Medical Thawing System Market: https://www.biospace.com/article/medical-thawing-system-market-to-undertake-strapping-growth-by-the-end-2030/
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antihormonal Cancer Therapies Market Strategic Analysis to Understand the Competitive Outlook of the Industry, 2030 here
News-ID: 2483523 • Views: …
More Releases from Transparency Market Research
Global Bakery Processing Equipment Market to Reach US$ 22.5 Billion by 2035 Repo …
The bakery industry is undergoing a major technological and structural transformation. As global consumers increasingly crave convenient, high-quality, and specialty baked products, the Bakery Processing Equipment Market is witnessing significant expansion. Valued at US$ 14.3 billion in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2035, ultimately reaching US$ 22.5 billion by the end of the forecast period.
The rise…
Bioinformatics Market to Reach USD 86.9 Billion by 2035 | Driven by AI Integrati …
The global bioinformatics market continues to gain substantial momentum as the fusion of biological science and data analytics redefines healthcare, biotechnology, and pharmaceutical research. According to recent industry data, the market was valued at US$ 22.2 billion in 2024 and is anticipated to grow at an impressive CAGR of 13.3% from 2025 to 2035, reaching US$ 86.9 billion by 2035. The acceleration in adoption of next-generation sequencing (NGS), increasing use…
Global Hydrogen-Based Renewable Energy Market to Hit US$ 34.9 Billion by 2035 | …
According to the latest industry analysis, the global hydrogen-based renewable energy market is entering a transformative growth phase. Valued at US$ 1.8 billion in 2024, the market is expected to expand at an exceptional CAGR of 32.5% between 2025 and 2035, reaching approximately US$ 34.9 billion by 2035. This growth trajectory reflects the critical role hydrogen will play in global energy transition strategies, with governments and industries accelerating adoption to…
Global Rose Water Market Set to Reach US$ 973 Million by 2035, Reports by Transp …
The global rose water market is poised for significant expansion, underpinned by the rising global inclination toward clean-label beauty, wellness-focused lifestyles, and botanical ingredients. According to the latest research, the industry was valued at US$ 453.0 million in 2024 and is projected to grow at a CAGR of 7.2% from 2025 to 2035, reaching US$ 973.0 million by 2035.
Rose water - a natural aromatic liquid derived through the steam distillation…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
